Autor: | Juan M. Herrerías, José M. Esteban, Antonio M. Caballero-Plasencia, Manuel Valenzuela-Barranco, Virginia Motilva, Catalina Alarcón, M. José Martín, Juan M. Herrerías Jr, Pilar Esteban |
---|---|
Rok vydání: | 2003 |
Předmět: |
medicine.medical_specialty
IBMX biology Physiology Chemistry Gastroenterology Phosphodiesterase Diclofenac Sodium Piroxicam digestive system diseases chemistry.chemical_compound medicine.anatomical_structure Endocrinology Enzyme inhibitor Internal medicine Gastric mucosa medicine biology.protein Phosphodiesterase inhibitor Zaprinast medicine.drug |
Zdroj: | Digestive Diseases and Sciences. 48:986-991 |
ISSN: | 0163-2116 |
DOI: | 10.1023/a:1023020201005 |
Popis: | Cyclic GMP plays an important role in maintaining homeostasis in the gastric mucosa. NSAIDs damage the mucosa by mechanisms that may be mediated by alterations in the intragastric concentration of cyclic GMP. To test this hypothesis we studied the effects of the oral administration of acetylsalicylic acid (100, 300, and 500 mg/kg), piroxicam (5, 10, and 20 mg/kg) and sodium diclofenac (10, 25, 50, and 100 mg/kg), and of their interaction with zaprinast (5 mg/kg) and IBMX (10 mg/kg), on intragastric concentrations of cyclic GMP and the gastric erosive index in rats. All determinations were done 3 hr after the NSAID was given. All NSAIDs induced dose-dependent decreases in mucosal concentrations of cyclic GMP, which correlated inversely with the surface area showing mucosal injury. In contrast, cyclic GMP concentrations remained normal, and no intragastric damage was seen in rats given zaprinast (cyclic GMP-specific phosphodiesterase inhibitor) or IBMX (non-specific phosphodiesterase inhibitor) or in combination with NSAIDs. These findings are in line with the hypothesis that cyclic GMP is involved in the biochemical mechanisms of NSAID-induced gastric injury. |
Databáze: | OpenAIRE |
Externí odkaz: |